Efficacy and safety of oral targeted therapies in pulmonary arterial hypertension: a meta‐analysis of randomized clinical trials
Author:
Affiliation:
1. Department of CardiologyNanjing First HospitalNanjing Medical UniversityNanjingJiangsuChina
2. Department of EchocardiographyFirst Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsuChina
Funder
Science and Technology Development Nanjing Medical University
Jiangsu Provincial Outstanding Medical Program
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894018798183
Reference46 articles.
1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Galie N;Eur Heart J,2016
2. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry;D’Alonzo GE;Ann Intern Med,1991
3. An evaluation of long‐term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza RL;Chest,2012
4. Treatment of pulmonary arterial hypertension with targeted therapies;O’Callaghan DS;Nat Rev Cardiol,2011
5. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial;Vizza CD;BMC Cardiovasc Disord,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis;Heart & Lung;2024-03
2. Deficiency of filamin A in smooth muscle cells protects against hypoxia‑mediated pulmonary hypertension in mice;International Journal of Molecular Medicine;2023-01-26
3. Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-08-02
4. Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis;Drug Delivery;2021-01-01
5. Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal;BMC Pulmonary Medicine;2020-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3